Cancer Program Changes Receive Top Readership in 2011

2011 was a year of monumental transformation and progress for the UC Cancer Institute, so it is no surprise that some of the top read stories for 2011 focused on cancer. Under the direction of George Atweh, MD, the UC Cancer Institute launched several key clinical programs in 2011, including the adult bone marrow transplant service and patient support/palliative care services. Through a collaborative effort with the UC Neuroscience Institute, a translational research program focused entirely understanding brain metastases was also established. 

Most read stories included: 

Hematology Oncology Fellowship Expansion 

Under the direction of George Atweh, MD, and Rekha Chaudhary, MD, UC’s hematology oncology fellowship program has been revamped with the specific aim of creating top-notch medical oncologists who are equipped with the skills—and desire—to pursue careers in academic medicine. For 2012, the program has expanded from nine to 12 fellows and utilizes a new education curriculum that includes guest speakers and training in clinical trial protocol development. »Read the full story

Cincinnati Native Trains at UC, Stays to Practice Oncology

UC Health’s newest attending radiation oncologist is Cincinnati proud: He grew up in Fairfield, completed medical school and residency at UC and launched his professional practice with UC Health in August 2011. Luke Pater, MD, joined UC Health Radiation Oncology and the College of Medicine faculty in September 2011. »Read the full story

Centralized Tumor Bank Gives Researchers Immediate Access to Samples

Cancer doesn’t wait or discriminate. When a new research idea sparks, time is of the essence. But gathering enough human tissue samples for testing can take years, delaying potential progress. This is where access to an established tumor bank is so critical to any major cancer research program. Under the direction of Hassana Fathallah, PhD, researchers affiliated with the UC Cancer Institute now have access to thousands of human tumor specimens—malignant and paired normal tissues, blood and urine—as well as associated clinical data. 

»Read the full story

 For a full recap of changes related to the UC Cancer Institute,

click here

.